GL1X · GenesisL1 explorer

Research workbench

Binding site elucidation and structure guided design of macrocyclic il-17A antagonists

Analyse Binding site elucidation and structure guided design of macrocyclic il-17A… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5HI3
Type
protein
Length
1,068 residues
Chains
7
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-17A; Cat-2000 Fab heavy chain; Cat-2000 Fab light chain; Synthetic il-17A…
UniProt
Q16552
Ligands
63O
Pockets
14 · best druggability 0.76

Structure

x-ray diffraction · 5 distinct chains · 8% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-17Aprotein1004% helix, 53% strandQ16552
BInterleukin-17Aprotein885% helix, 57% strandQ16552
C, HCat-2000 Fab heavy chainprotein22010% helix, 53% strand—
D, LCat-2000 Fab light chainprotein2138% helix, 50% strand—
ISynthetic il-17A peptide inhibitorprotein1450% helix, 36% strand—

Ligands and binding sites

  • 63O · N-(4-{2-[({1-[2-(dimethylamino)-2-oxoethyl]cyclopentyl}acetyl)amino]ethyl}phenyl)-2-fluoro-Nalpha-[(1-methyl-1H-pyrazol-5-yl)carbonyl]-L-phenylalaninamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111530.760.789563O
22660.660.8247empty
34510.580.7461empty
41380.550.8235empty
53470.540.7438empty

Interfaces

11 interfaces between chains.

  • H–L · 1847 Ų buried · 19 hydrogen bonds · protein-protein
  • C–D · 1802 Ų buried · 19 hydrogen bonds · protein-protein
  • A–B · 1174 Ų buried · 13 hydrogen bonds · protein-protein
  • A–I · 669 Ų buried · 12 hydrogen bonds · protein-protein
  • A–D · 363 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide (disulfide).

Compared structures

  • 5HI3 · Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists · the same entry in another collection · chain L against L, TM-score 1.00
  • Q16552 · AlphaFold monomer V2.0 prediction for interleukin-17A (Q16552) · a predicted model of the same protein · chain B against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.